Cotinga Pharmaceuticals ROIC
¿Qué es el ROIC de Cotinga Pharmaceuticals?
El ROIC de Cotinga Pharmaceuticals, Inc. es -183.57%
¿Cuál es la definición de ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC de compañías en Sector Health Care en TSXV en comparadas con Cotinga Pharmaceuticals
¿Qué hace Cotinga Pharmaceuticals?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Empresas con roic similar a Cotinga Pharmaceuticals
- Winc tiene ROIC de -185.73%
- Appili Therapeutics Inc tiene ROIC de -185.42%
- 22nd Century Inc tiene ROIC de -184.82%
- Reviva Pharmaceuticals tiene ROIC de -184.14%
- Graycliff Exploration tiene ROIC de -184.13%
- Smart Cannabis tiene ROIC de -183.89%
- Cotinga Pharmaceuticals tiene ROIC de -183.57%
- Comprehensive Healthcare Systems tiene ROIC de -183.21%
- Agritek tiene ROIC de -182.52%
- Neovasc tiene ROIC de -182.46%
- Biolife Sciences Inc tiene ROIC de -182.26%
- Galectin Therapeutics Inc tiene ROIC de -181.99%
- Wize Pharma tiene ROIC de -181.64%